Company profile
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a
- CEO
- Mr. Frank D. Heuszel Esq., J.D.
- Headquarters
- Houston, TX, United States
- Employees
- 2
- IPO date
- Sep 16, 2024
- Sector
- Healthcare
- Industry
- Biotechnology